Intermediate risk Primary Myelofibrosis (PMF)

DrugDrug NameDrug Description
DB11697PacritinibA kinase inhibitor used for the treatment of primary and secondary myelofibrosis in adult patients with significantly reduced platelet counts.
DrugDrug NamePhaseStatusCount